As a Biotech CEO, steering a company through the dynamic landscape of innovation comes with a unique set of challenges, and at the heart of these challenges lies the intricate realm of Intellectual Property (IP). The biotech sector, where breakthrough discoveries can reshape industries and improve lives, demands a
keen understanding of how to preserve, protect, and leverage IP strategically. Click here to download the document.

About the author.


20 years of experience in international business development in the pharmaceutical industry. Head of commercial operations and business development for Bristol-Myers Squibb in 16 Latin American countries. Global management consultant. Speaks French and Spanish fluently. Completed nine transactions in global markets in the past three years.

No Comments. Leave a comment  

Leave a Reply

Your email address will not be published. Required fields are marked *